Literature DB >> 55328

Studies with the macrophage migration inhibition (MMI) test in patients with malignant disease.

P A Light, A W Preece, H A Waldron.   

Abstract

Macrophage migration inhibition (MMI) tests have been carried out using lymphocytes from twenty-six patients with malignant disease and from twenty-two other subjects. The antigens used were the same as those employed in the macrophage electrophoretic mobility (MEM) test. The results indicate that the inforation obtained using the MMI test is similar to that found with the MEM test.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 55328      PMCID: PMC1538295     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  14 in total

1.  DELAYED HYPERSENSITIVITY IN VITRO. I. THE SPECIFICITY OF INHIBITION OF CELL MIGRATION BY ANTIGENS.

Authors:  J R DAVID; S AL-ASKARI; H S LAWRENCE; L THOMAS
Journal:  J Immunol       Date:  1964-08       Impact factor: 5.422

2.  In vitro cell migration as a model for delayed hypersensitivity.

Authors:  M GEORGE; J H VAUGHAN
Journal:  Proc Soc Exp Biol Med       Date:  1962-11

3.  The macrophage electrophoretic migration test in cancer.

Authors:  A H Goldstone; L Kerr; W J Irvine
Journal:  Clin Exp Immunol       Date:  1973-07       Impact factor: 4.330

4.  Macrophage-electrophoretic-mobility (M.E.M.) test for malignant disease. An independent confirmation.

Authors:  J A Pritchard; J L Moore; W H Sutherland; C A Joslin
Journal:  Lancet       Date:  1972-09-23       Impact factor: 79.321

5.  Technical aspects of the macrophage electrophoretic mobility (MEM) test for malignant disease.

Authors:  J A Pritchard; J L Moore; W H Sutherland; C A Joslin
Journal:  Br J Cancer Suppl       Date:  1973-08

6.  Lymphocyte sensitivity in cancer.

Authors:  D Hughes; D W Paty
Journal:  Br Med J       Date:  1971-06-26

7.  Lymphocyte sensitisation: an in-vitro test for cancer?

Authors:  E J Field; E A Caspary
Journal:  Lancet       Date:  1970-12-26       Impact factor: 79.321

8.  The macrophage electrophoretic mobility (MEM) test for malignant disease. Further clinical investigations and studies on macrophage slowing factors.

Authors:  A W Preece; P A Light
Journal:  Clin Exp Immunol       Date:  1974-12       Impact factor: 4.330

9.  Mechanism of a reaction in vitro associated with delayed-type hypersensitivity.

Authors:  B R Bloom; B Bennett
Journal:  Science       Date:  1966-07-01       Impact factor: 47.728

10.  Specific lymphocyte sensitization in cancer: is there a common antigen in human malignant neoplasia?

Authors:  E A Caspary; E J Field
Journal:  Br Med J       Date:  1971-06-12
View more
  8 in total

1.  Cellular hypersensitivity to autologous tumor extract in patients with breast carcinoma.

Authors:  T Akiyoshi; Y Nakamura; M Kawaguchi; H Tsuji
Journal:  Jpn J Surg       Date:  1978-09

2.  Reactivity of lymphocytes to basic proteins prepared from brain glioma and stomach cancer with MEM test.

Authors:  Y D Shi; Z S Tang; Z J Lian; C Z Lu; B G Xiao
Journal:  Br J Cancer       Date:  1981-04       Impact factor: 7.640

3.  Failure to induce transplantation immunity to an SV40-induced tumour in hamsters immunized with basic proteins of myelin or malignant tissues.

Authors:  D J Flavell; C W Potter
Journal:  Br J Cancer       Date:  1978-07       Impact factor: 7.640

4.  Macrophage electrophoretic mobility (MEM) with myelin basic protein.

Authors:  G A Rawlins; J M Wood; K D Bagshawe
Journal:  Br J Cancer       Date:  1976-12       Impact factor: 7.640

5.  Cell-mediated immunity to encephalitogenic factor (MMI test) in women with cervical dysplasia and carcinoma in situ: the effects of serum.

Authors:  D J Flavell; A Singer; C W Potter
Journal:  Br J Cancer       Date:  1978-09       Impact factor: 7.640

6.  Cellular immunity to encephalitogenic factor as measured by macrophage migration inhibition during tumour induction and growth.

Authors:  D J Flavell; J Goepel; C W Potter; I Carr
Journal:  Br J Cancer       Date:  1978-05       Impact factor: 7.640

7.  Responses of cancer patients in the MEM test: not just a function of charge on basic proteins.

Authors:  A Shaw; G Ettin; T A McPherson
Journal:  Br J Cancer       Date:  1976-07       Impact factor: 7.640

8.  Cellular immunity to encephalitogenic factor in man as measured by the macrophage migration inhibition test: the effects of serum.

Authors:  D J Flavell; C W Potter
Journal:  Br J Cancer       Date:  1978-01       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.